Abstract
Despite the importance of symptom control in the cancer population, few studies have systematically assessed the prevalence and characteristics of symptoms or the interactions between various symptom characteristics and other factors related to quality of life (QOL). As part of a validation study of a new symptom assessment instrument, inpatients and out-patients with prostate, colon, breast or ovarian cancer were evaluated using the Memorial Symptom Assessment Scale and other measures of psychological condition, performance status, symptom distress and overall quality of life. The mean age of the 243 avaluable patients was 55.5 years (range 23–86 years); over 60% were women and almost two-thirds had metastatic disease. The Karnofsky Performance Status (KPS) score was≤80 in 49.8% and 123 were inpatients at the time of assessment. Across tumour types, 40–80% experienced lack of energy, pain, feeling drowsy, dry mouth, insomnia, or symptoms indicative of psychological distress. Although symptom characteristics were variable, the proportion of patients who described a symptom as relatively intense or frequent always exceeded the proportion who reported it as highly distressing. The mean (±SD, range) number of symptoms per patient was 11.5±6.0 (0–25); inpatients had more symptoms than outpatients (13.5±5.4 vs. 9.7±6.0, p<0.002) and those with KPS≤80 had more symptoms than those with KPS>80 (14.8±5.5 vs. 9.2±4.9, p<0.0001). The number of symptoms was highly associated with heightened psychological distress and poorer quality of life (for example, r=0.67 for the relationship with the Functional Living Index-Cancer, a QOL measure). These data clarify the prevalence and characteristics of cancer-related symptoms and suggest that the number of symptoms per patient may be a useful quality of life indicator.
Similar content being viewed by others
References
Cella DF. Quality of life: the concept. J Palliative Care 1992; 8: 8–13.
Calman KC. Definitions and dimensions of quality of life. In: Aaronson NK, Beckmann J, eds. The Quality of Life of Cancer Patients. New York: Raven Press, 1987: 1–10.
Curtis EB, Kretch R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliative Care 1991; 7: 25–29.
Dunphy KP, Amesbury BDW. A comparison of hospice and homecare patients: patterns of referral, patient characteristics and predictors of place of death. Palliative Med 1990; 4: 105–11.
Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988; 148: 1586–1591.
Dunlop GM. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far-advanced cancer: student paper. Palliative Med 1989; 4: 37–43.
Derogatis LR, Morrow GR, Fetting J et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751–757.
Craig TJ, Abeloff MD. Psychiatric symptomatology among hospitalized cancer patients. Am J Psych 1974; 131: 1323–1336.
Levine PM, Silberfarb PM, Lipowski ZJ. Mental disorders in cancer patients: a study of 100 psychiatric referrals. Cancer 1978; 42: 1386–1391.
Massie MJ, Holland JC. Overview of normal reactions and prevalence of psychiatric disorders. In: Holland JC, Rowland JH, eds. Handbook of Psychooncology. New York: Oxford University Press, 1989: 273–282.
Richardson JL, Marks G, Levine A. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 1988; 6: 1746–1752.
Ventafridda V, De Conno F, Ripamonti C, et al. Quality of life assessment during a palliative care programme. Ann Oncol 1990; 1: 415–420.
Hockley JM, Dunlop R, Davies RJ. Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J 1988; 296: 1715–1717.
Coyle N, Adelhardt J, Foley KM et al. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Management 1990; 5: 83–93.
Brescia FJ, Adler D, Gray G, et al. Hospitalized advanced cancer patients: a profile. J Pain Symptom Management 1990; 5: 221–227.
Baines M. Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Management 1988; 3: 81–85.
McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs 1978; 1: 373–378.
de Haes JCJM, van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034–1038.
Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer, in press.
Fishman B, Pasternak S, Wallenstein S, et al. The Memorial Pain Assessment Care: a valid instrument for the assessment of cancer pain. Cancer 1987; 60: 1151–1157.
Brook RH, Ware JE, Davies-Avery A, et al. Conceptualization and measurement of health for adults. In: The Health Insurance Study, Vol VIII: Overview. Santa Monica: Rand, 1979.
Ware JE, Johnston SA, Davies-Avery A, et al. Conceptualization and measurement of health for adults. In: The Health Insurance Study, Vol III: Mental Health. Santa Monica: Rand, 1979.
Veit CT, Ware JE. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983; 51: 730–742.
Kornblith AB, Hollis D, Phillips CA, et al. Dose-related effect of megestrol acetate upon quality of life in advanced breast cancer patients. Proc ASCO 1992; 11: 1305.
Schipper H, Clinch J, McMurray A, et al. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984; 2: 472–483.
Kukull WA, McCorkle R, Driever M. Symptom distress, psychosocial variables and survival from lung cancer. J Psychosoc Oncol 1986; 4: 91–104.
Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using Karnofsky Performance Status. Cancer 1980; 40: 2220–2224.
Welch JM, Barlow D, Richardson PH. Symptoms of HIV disease. Palliative Med 1991; 5: 46–51.
Author information
Authors and Affiliations
Additional information
Supported by American Cancer Society Grant PRB-78 and by NIH-CA52477.
Rights and permissions
About this article
Cite this article
Portenoy, R.K., Thaler, H.T., Kornblith, A.B. et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3, 183–189 (1994). https://doi.org/10.1007/BF00435383
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00435383